Rh2 achieves anti-tumor activity by inhibiting tumor cell migration, upregulating the pro-apoptotic gene Bax, downregulating the anti-apoptotic gene Bcl-2, and disrupting the HSP90A-CDC37 system in hepatocellular carcinoma cells [149,150]. This evidence concerns the gene RHAG and neoplasm.